Dyskerin Polyclonal Antibody

货号：ES5006
价格：面议
点击：1868

产品介绍

抗体信息

应用	WB;IHC-p;IF/ICC;ELISA
反应种属	Human;Mouse;Rat
别称	DKC1; NOLA4; H/ACA ribonucleoprotein complex subunit 4; CBF5 homolog; Dyskerin; Nopp140-associated protein of 57 kDa; Nucleolar protein NAP57; Nucleolar protein family A member 4; snoRNP protein DKC1

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Sarilumab Neutralizing Recombinant Antibody \|抗萨瑞鲁单抗中和重组抗体(靶标：萨瑞鲁单抗中和抗体)	350
Anti-Sarilumab Neutralizing Recombinant Antibody \|抗萨瑞鲁单抗中和重组抗体(靶标：萨瑞鲁单抗中和抗体)	318
Anti-Sarilumab Neutralizing Recombinant Antibody \|抗萨瑞鲁单抗中和重组抗体(靶标：萨瑞鲁单抗中和抗体)	305
Anti-Sarilumab Neutralizing Recombinant Antibody \|抗萨瑞鲁单抗中和重组抗体(靶标：萨瑞鲁单抗中和抗体)	325
Anti-Durvalumab Non-Neutralizing Recombinant Antibody \|程度伐利尤单抗非中和重组抗体(靶标：度伐利尤单抗非中和抗体)	589
Anti-Durvalumab Non-Neutralizing Recombinant Antibody \|抗度伐利尤单抗非中和重组抗体(靶标：度伐利尤单抗非中和抗体)	561
Anti-Durvalumab Neutralizing Recombinant Antibody \|抗度伐利尤单抗中和重组抗体(靶标：度伐利尤单抗中和抗体)	365
Anti-Durvalumab Neutralizing Recombinant Antibody \|抗度伐利尤单抗中和重组抗体(靶标：度伐利尤单抗中和抗体)	412
Anti-Durvalumab Neutralizing Recombinant Antibody \|抗度伐利尤单抗中和重组抗体(靶标：度伐利尤单抗中和抗体)	352
Anti-Durvalumab Neutralizing Recombinant Antibody \|抗度伐利尤单抗中和重组抗体(靶标：度伐利尤单抗中和抗体)	339
Anti-Atezolizumab Non-Neutralizing Recombinant Antibody \|抗阿替利珠单抗非中和重组抗体(靶标：阿替利珠单抗非中和抗体)	397
Anti-Atezolizumab Non-Neutralizing Recombinant Antibody \|抗阿替利珠单抗非中和重组抗体(靶标：阿替利珠单抗非中和抗体)	343
Anti-Atezolizumab Neutralizing Recombinant Antibody \|抗阿替利珠单抗中和重组抗体(靶标：阿替利珠单抗中和抗体)	350
Anti-Atezolizumab Neutralizing Recombinant Antibody \|抗阿替利珠单抗中和重组抗体(靶标：阿替利珠单抗中和抗体)	405
Anti-Panitumumab Non-Neutralizing Recombinant Antibody \|抗帕尼单抗非中和重组抗体(靶标：帕尼单抗非中和抗体)	532
Anti-Panitumumab Non-Neutralizing Recombinant Antibody \|抗帕尼单抗非中和重组抗体(靶标：帕尼单抗非中和抗体)	347
Anti-Panitumumab Non-Neutralizing Recombinant Antibody \|抗帕尼单抗非中和重组抗体(靶标：帕尼单抗非中和抗体)	290
Anti-Panitumumab Neutralizing Recombinant Antibody \|抗帕尼单抗中和重组抗体(靶标：帕尼单抗中和抗体)	270
Anti-Panitumumab Neutralizing Recombinant Antibody \|抗帕尼单抗中和重组抗体(靶标：帕尼单抗中和抗体)	256
Anti-Panitumumab Neutralizing Recombinant Antibody \|抗帕尼单抗中和重组抗体(靶标：帕尼单抗中和抗体)	269